xamoterol has been researched along with dronabinol in 2 studies
Studies (xamoterol) | Trials (xamoterol) | Recent Studies (post-2010) (xamoterol) | Studies (dronabinol) | Trials (dronabinol) | Recent Studies (post-2010) (dronabinol) |
---|---|---|---|---|---|
269 | 80 | 17 | 8,307 | 785 | 3,094 |
Protein | Taxonomy | xamoterol (IC50) | dronabinol (IC50) |
---|---|---|---|
Cannabinoid receptor 1 | Rattus norvegicus (Norway rat) | 0.218 | |
Cannabinoid receptor 1 | Homo sapiens (human) | 0.0028 | |
Cannabinoid receptor 2 | Homo sapiens (human) | 0.0095 | |
Cannabinoid receptor 2 | Rattus norvegicus (Norway rat) | 0.218 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
2 other study(ies) available for xamoterol and dronabinol
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |